• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素 A 受体型 1(ACVR1)在原发性局限性多汗症发病机制中的作用。

Involvement of activin a receptor type 1 (ACVR1) in the pathogenesis of primary focal hyperhidrosis.

机构信息

Department of Thoracic Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Gulou District, Fuzhou, People's Republic of China; Department of Thoracic Surgery, First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, People's Republic of China.

Department of Thoracic Surgery, First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, People's Republic of China.

出版信息

Biochem Biophys Res Commun. 2020 Jul 23;528(2):299-304. doi: 10.1016/j.bbrc.2020.05.052. Epub 2020 May 27.

DOI:10.1016/j.bbrc.2020.05.052
PMID:32473755
Abstract

The pathogenesis of primary focal hyperhidrosis (PFH) is still not clear. PFH is thought to be a genetic disease. Whether activin A receptor type 1 (ACVR1) is involved in the pathogenesis of PFH is unknown. In this study, the expression of ACVR1 in sweat glands of patients with PAH was detected by western blot and immunofluorescence. The primary sweat gland cells obtained from primary axillary hyperhidrosis (PAH) patients were transfected with acvr1 vector. Cell proliferation, apoptosis and cell cycling of gland cells were measured after transfection with acvr1 vector. The mRNA and protein expression of aquaporin 5 (AQP5) and Na:K:2Cl Cotransporter 1 (NKCC1/SLC12A2) were detected. Our data showed that ACVR1 expression in axillary sweat gland tissue of PAH patients was significantly higher than that of normal control group. The function of ACVR1 was further investigated in the gland cells obtained from PAH patients. Compared with NC group, ACVR1 overexpression significantly promoted the proliferation of sweat gland cells and inhibited the apoptosis of sweat gland cells. Meanwhile, ACVR1 overexpression significantly reduced the percentage of cells in G0/G1 and G2/M phases, and increased the percentage of cells in S phase. In addition, ACVR1 overexpression significantly promoted the expression of AQP5 and NKCC1 at both mRNA and protein levels. Together, ACVR1 expression is related to PFH and ACVR1 overexpression can promote the proliferation of sweat gland cells and inhibit apoptosis by promoting the expression of AQP5 and NKCC1.

摘要

原发性局部多汗症(PFH)的发病机制尚不清楚。PFH 被认为是一种遗传病。ACVR1 是否参与 PFH 的发病机制尚不清楚。在这项研究中,通过 Western blot 和免疫荧光检测了 PFH 患者汗腺中 ACVR1 的表达。从原发性腋窝多汗症(PAH)患者中获得的原代汗腺细胞用 acvr1 载体转染。转染 acvr1 载体后,测量腺细胞的增殖、凋亡和细胞周期。检测水通道蛋白 5(AQP5)和 Na:K:2Cl 共转运蛋白 1(NKCC1/SLC12A2)的 mRNA 和蛋白表达。我们的数据表明,PAH 患者腋窝汗腺组织中 ACVR1 的表达明显高于正常对照组。进一步研究了从 PAH 患者获得的腺细胞中的 ACVR1 功能。与 NC 组相比,ACVR1 过表达显著促进了汗腺细胞的增殖并抑制了汗腺细胞的凋亡。同时,ACVR1 过表达显著降低了 G0/G1 和 G2/M 期细胞的百分比,增加了 S 期细胞的百分比。此外,ACVR1 过表达显著促进了 AQP5 和 NKCC1 在 mRNA 和蛋白水平的表达。总之,ACVR1 的表达与 PFH 有关,ACVR1 的过表达通过促进 AQP5 和 NKCC1 的表达可以促进汗腺细胞的增殖和抑制凋亡。

相似文献

1
Involvement of activin a receptor type 1 (ACVR1) in the pathogenesis of primary focal hyperhidrosis.激活素 A 受体型 1(ACVR1)在原发性局限性多汗症发病机制中的作用。
Biochem Biophys Res Commun. 2020 Jul 23;528(2):299-304. doi: 10.1016/j.bbrc.2020.05.052. Epub 2020 May 27.
2
Involvement of aquaporin 5 and Na-K-2Cl cotransporter 1 in the pathogenesis of primary focal hyperhidrosis: evidence from the primary sweat gland cell culture.水通道蛋白5和钠-钾-2氯共转运体1在原发性局灶性多汗症发病机制中的作用:来自原代汗腺细胞培养的证据
Am J Physiol Cell Physiol. 2024 Jan 1;326(1):C206-C213. doi: 10.1152/ajpcell.00274.2023. Epub 2023 Dec 4.
3
Upregulation of ITGB6 in primary palmar hyperhidrosis.原发性手掌多汗症中 ITGB6 的上调。
Adv Clin Exp Med. 2023 Dec;32(12):1413-1422. doi: 10.17219/acem/162178.
4
Overexpression of AQP5 Was Detected in Axillary Sweat Glands of Primary Focal Hyperhidrosis Patients.在原发性局灶性多汗症患者的腋窝汗腺中检测到水通道蛋白5(AQP5)过表达。
Dermatology. 2016;232(2):150-5. doi: 10.1159/000444081. Epub 2016 Mar 2.
5
CHRNA1 promotes the pathogenesis of primary focal hyperhidrosis.CHRNA1 促进原发性局限性多汗症的发病机制。
Mol Cell Neurosci. 2021 Mar;111:103598. doi: 10.1016/j.mcn.2021.103598. Epub 2021 Jan 19.
6
PAI1 inhibits the pathogenesis of primary focal hyperhidrosis by targeting CHRNA1.PAI1 通过靶向 CHRNA1 抑制原发性局限性多汗症的发病机制。
Orphanet J Rare Dis. 2023 Jul 21;18(1):205. doi: 10.1186/s13023-023-02808-0.
7
The secretory clear cell of the eccrine sweat gland as the probable source of excess sweat production in hyperhidrosis.大汗腺的分泌性透明细胞可能是多汗症中过度出汗的来源。
Exp Dermatol. 2011 Dec;20(12):1017-20. doi: 10.1111/j.1600-0625.2011.01361.x. Epub 2011 Oct 13.
8
Localization of Na(+)-K(+)-ATPase α/β, Na(+)-K(+)-2Cl-cotransporter 1 and aquaporin-5 in human eccrine sweat glands.钠钾ATP酶α/β、钠钾氯共转运体1及水通道蛋白5在人外泌汗腺中的定位
Acta Histochem. 2014 Oct;116(8):1374-81. doi: 10.1016/j.acthis.2014.08.010. Epub 2014 Sep 11.
9
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis.Chrna1 拮抗剂可预防原发性局限性多汗症的发病机制。
Ann Clin Transl Neurol. 2022 Jun;9(6):786-794. doi: 10.1002/acn3.51558. Epub 2022 Apr 8.
10
A novel organotypic 3D sweat gland model with physiological functionality.一种具有生理功能的新型器官型三维汗腺模型。
PLoS One. 2017 Aug 10;12(8):e0182752. doi: 10.1371/journal.pone.0182752. eCollection 2017.

引用本文的文献

1
Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model.在小鼠模型中,虎杖苷通过作用于水通道蛋白5改善多汗症。
Front Pharmacol. 2025 Aug 13;16:1589143. doi: 10.3389/fphar.2025.1589143. eCollection 2025.
2
Efficacy and safety of radiofrequency ablation versus surgical sympathectomy in palmar hyperhidrosis.射频消融与手术交感神经切断术治疗手掌多汗症的疗效和安全性。
Sci Rep. 2024 Apr 1;14(1):7620. doi: 10.1038/s41598-024-57834-0.
3
The prognostic value and potential immunotherapeutic efficacy of in treating gastric cancer.
(此处原文不完整,缺少关键信息,无法准确翻译完整句子。推测可能是某个因素等在治疗胃癌方面的预后价值和潜在免疫治疗疗效。)
J Gastrointest Oncol. 2024 Feb 29;15(1):63-85. doi: 10.21037/jgo-23-984. Epub 2024 Feb 28.
4
Aquaporin-5 Dynamic Regulation.水通道蛋白-5 的动态调控。
Int J Mol Sci. 2023 Jan 18;24(3):1889. doi: 10.3390/ijms24031889.
5
Aquaporins in Glandular Secretion.腺分泌中的水通道蛋白。
Adv Exp Med Biol. 2023;1398:225-249. doi: 10.1007/978-981-19-7415-1_16.
6
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.发现新型吡唑并嘧啶作为强效、选择性且口服生物可利用的ALK2抑制剂。
ACS Med Chem Lett. 2022 Jun 22;13(7):1159-1164. doi: 10.1021/acsmedchemlett.2c00206. eCollection 2022 Jul 14.
7
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis.Chrna1 拮抗剂可预防原发性局限性多汗症的发病机制。
Ann Clin Transl Neurol. 2022 Jun;9(6):786-794. doi: 10.1002/acn3.51558. Epub 2022 Apr 8.
8
Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.作为人类疾病靶点的激活素受体样激酶2(ALK2)/激活素A受体1型(ACVR1)的累积知识。
Biomedicines. 2021 Jun 26;9(7):736. doi: 10.3390/biomedicines9070736.